Products from BPS Bioscience require a minimum order value above 400€
Background: Induced myeloid leukemia cell differentiation protein (MCL-1) is part of the BCL-2 family of proteins that regulates apoptosis. The intrinsic (mitochondrial) apoptotic pathway is activated by intracellular signals strictly controlled by the BCL-2 family of proteins and are grouped into the antiapoptotic, activator, and sensitizer subsets. All function through complex interactions to regulate the integrity of the mitochondrial membrane. As part of the antiapoptotic subset, MCL-1 inhibits mitochondrial outer membrane permeabilization (MOMP) and the release of cytochrome C from mitochondria. MCL-1 is essential for the survival of various cell types that include the nervous system, cardiomyocytes and lymphocytes. Overexpression of MCL-1 is frequently observed inmany tumor types and is closely associated with tumorigenesis and drug resistance. Because of its ability to strictly regulate cell fate, MCL-1 is a target of interest for many drug therapies.
CAS Number: 1668553-26-1
Description: A-1210477 is a potent and selective inhibitor of MCL-1 with a Ki of 0.45 nM1. A-1210477 specifically binds MCL-1 and promotes apoptosis of cancer cells in an MCL-1-dependent manner.2
Format: Solid.
Purity: ≥90%
Storage Stability: Powder-20°C3 years 4°C2 yearsIn solvent-80°C2 years -20°C1 year
Target: MCL-1
Warnings: Avoid freeze/thaw cycles.
Biosafety Level: Not applicable (BSL-1)
References: 1. Leverson JD, et al., 2015 Cell Death Dis. 6:e1590. 2. Qing Wang, et al., 2019 Oncol Lett. 18(5): 5481-5489.
Deutsch
English
